Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

Isakov V, Chulanov V, Abdurakhmanov D, et al. Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden. Infect Dis (Lond). 2019;51(2):131-139.

Publication Type:

Journal Article

Authors:

Isakov, V; Chulanov, V; Abdurakhmanov, D; et, al

Source:

Infect Dis (Lond), Volume 51, Issue 2, p.131-139 (2019)

Cited On:

Treatment-Naive Genotype 3 Without Cirrhosis

Export Citation:

RIS Format

Top